References
- Michielan A, D’Inca R. Intestinal permeability in inflammatory bowel disease: pathogenesis, clinical evaluation, and therapy of leaky gut. Mediators Inflamm. 2015;2015:628157. doi: https://doi.org/10.1155/2015/628157.
- Cardoso-Silva D, Delbue D, Itzlinger A, Moerkens R, Withoff S, Branchi F, Schumann M. Intestinal barrier function in gluten-related disorders. Nutrients. 2019;11(10):2325. doi:https://doi.org/10.3390/nu1110
- Soler AP, Miller RD, Laughlin KV, Carp NZ, Klurfeld DM, Mullin JM. Increased tight junctional permeability is associated with the development of colon cancer. Carcinogenesis. 1999;20(8):1425–31. doi:https://doi.org/10.1093/carcin/20.8.1425
- Monteiro CA, Cannon G, Levy RB, Moubarac J-C, Louzada ML, Rauber F, Khandpur N, Cediel G, Neri D, Martinez-Steele E, et al. Ultra-processed foods: what they are and how to identify them. Public Health Nutr. 2019;22(5):936–41. doi: https://doi.org/10.1017/S1368980018003762.
- Martinez Steele E, Popkin BM, Swinburn B, Monteiro CA. The share of ultra-processed foods and the overall nutritional quality of diets in the US: evidence from a nationally representative cross-sectional study. Popul Health Metr. 2017;15(1):6. doi: https://doi.org/10.1186/s12963-017-0119-3.
- Juul F, Martinez-Steele E, Parekh N, Monteiro CA, Chang VW. Ultra-processed food consumption and excess weight among US adults. Br J Nutr. 2018;120(1):90–100. doi:https://doi.org/10.1017/S0007114518001046
- Monteiro CA, Moubarac J-C, Levy RB, Canella DS, Louzada MLdC, Cannon G. Household availability of ultra-processed foods and obesity in nineteen European countries. Public Health Nutr. 2018;21(1):18–26. doi: https://doi.org/10.1017/S1368980017001379.
- Monteiro C, Cannon G, Lawrence M, Louzada ML, Machado P. 2019. Ultra-processed foods, diet quality, and health using the NOVA classification system. Rome, FAO.
- Stuckler D, McKee M, Ebrahim S, Basu S. Manufacturing epidemics: the role of global producers in increased consumption of unhealthy commodities including processed foods, alcohol, and tobacco. PLoS Med. 2012;9(6):e1001235. doi: https://doi.org/10.1371/journal.pmed.1001235.
- Baraldi LG, Martinez Steele E, Canella DS, Monteiro CA. Consumption of ultra-processed foods and associated sociodemographic factors in the USA between 2007 and 2012: evidence from a nationally representative cross-sectional study. BMJ Open. 2018;8(3):e020574. doi: https://doi.org/10.1136/bmjopen-2017-020574.
- Moubarac J-C, Martins APB, Claro RM, Levy RB, Cannon G, Monteiro CA. Consumption of ultra-processed foods and likely impact on human health. Evidence from Canada. Public Health Nutr. 2013;16(12):2240–8. doi: https://doi.org/10.1017/S1368980012005009.
- Popkin BM. Nutrition, agriculture and the global food system in low and middle income countries. Food Policy. 2014;47:91–6. doi: https://doi.org/10.1016/j.foodpol.2014.05.001.
- Rauber F, da Costa Louzada ML, Steele E, Millett C, Monteiro CA, Levy RB. Ultra-processed food consumption and chronic non-communicable diseases-related dietary nutrient profile in the UK (2008–2014). Nutrients. 2018;10(5):587. doi:https://doi.org/10.3390/nu10050
- Sartorelli DS, Crivellenti LC, Zuccolotto DCC, Franco LJ. Relationship between minimally and ultra-processed food intake during pregnancy with obesity and gestational diabetes mellitus. Cad Saude Publica. 2019;35(4):e00049318. doi: https://doi.org/10.1590/0102-311X00049318.
- Nasreddine L, Tamim H, Itani L, Nasrallah MP, Isma’eel H, Nakhoul NF, Abou-Rizk J, Naja F. A minimally processed dietary pattern is associated with lower odds of metabolic syndrome among Lebanese adults. Public Health Nutr. 2018;21(1):160–71. doi: https://doi.org/10.1017/S1368980017002130.
- Galvão De Podestá OP, Peres SV, Salaroli LB, Cattafesta M, De Podestá JRV, von Zeidler SLV, de Oliveira JC, Kowalski LP, Ikeda MK, Brennan P, et al. Consumption of minimally processed foods as protective factors in the genesis of squamous cell carcinoma of the head and neck in Brazil. PloS One. 2019;14(7):e0220067. doi: https://doi.org/10.1371/journal.pone.0220067.
- Srour B, Fezeu LK, Kesse-Guyot E, Alles B, Mejean C, et al. Ultra-processed food intake and risk of cardiovascular disease: prospective cohort study (NutriNet-Sante). BMJ. 2019;365:l1451.: doi:https://doi.org/10.1136/bmj.l1451
- Srour B, Fezeu LK, Kesse-Guyot E, Allès B, Debras C, Druesne-Pecollo N, Chazelas E, Deschasaux M, Hercberg S, Galan P, et al. Ultraprocessed food consumption and risk of type 2 diabetes among participants of the NutriNet-Sante prospective cohort. JAMA Intern Med. 2020;180(2):283. doi:https://doi.org/10.1001/jamainternmed.2019.5942
- Fiolet T, Srour B, Sellem L, Kesse-Guyot E, Alles B, et al. Consumption of ultra-processed foods and cancer risk: results from NutriNet-Sante prospective cohort. BMJ. 2018;360:k322. doi:https://doi.org/10.1136/bmj.k322
- Chassaing B, Koren O, Goodrich JK, Poole AC, Srinivasan S, Ley RE, Gewirtz AT. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature. 2015;519(7541):92–6. doi: https://doi.org/10.1038/nature14232.
- Viennois E, Merlin D, Gewirtz AT, Chassaing B. Dietary emulsifier-induced low-grade inflammation promotes colon carcinogenesis. Cancer Res. 2017;77(1):27–40. doi: https://doi.org/10.1158/0008-5472.CAN-16-1359.
- Menard S, Cerf-Bensussan N, Heyman M. Multiple facets of intestinal permeability and epithelial handling of dietary antigens. Mucosal Immunol. 2010;3(3):247–59. doi: https://doi.org/10.1038/mi.2010.5.
- Gewirtz AT, Simon PO, Schmitt CK, Taylor LJ, Hagedorn CH, O’Brien AD, Neish AS, Madara JL. Salmonella typhimurium translocates flagellin across intestinal epithelia, inducing a proinflammatory response. J Clin Invest. 2001;107(1):99–109. doi: https://doi.org/10.1172/JCI10501.
- Guo S, Al-Sadi R, Said HM, Ma TY. Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14. Am J Pathol. 2013;182(2):375–87. doi: https://doi.org/10.1016/j.ajpath.2012.10.014.
- Ziegler TR, Luo M, Estívariz CF, Moore DA, Sitaraman SV, Hao L, Bazargan N, Klapproth J-M, Tian J, Galloway JR, et al. Detectable serum flagellin and lipopolysaccharide and upregulated anti-flagellin and lipopolysaccharide immunoglobulins in human short bowel syndrome. Am J Physiol Regul Integr Comp Physiol. 2008;294(2):R402–10. doi: https://doi.org/10.1152/ajpregu.00650.2007.
- Chassaing B, Kumar M, Baker MT, Singh V, Vijay-Kumar M. Mammalian gut immunity. Biomed J. 2014;37(5):246–58. doi: https://doi.org/10.4103/2319-4170.130922.
- Otvos JD, Shalaurova I, Wolak-Dinsmore J, Connelly MA, Mackey RH, Stein JH, Tracy RP. GlycA: a composite nuclear magnetic resonance biomarker of systemic inflammation. Clin Chem. 2015;61(5):714–23. doi:https://doi.org/10.1373/clinchem.2014.232918
- Brantley KD, Hartman TJ, Patel AV, Gapstur SM, Flanders WD, McCullough ML. Test–retest reproducibility of adult-reported high school diet varies among racially and ethnically diverse US men and women. J Nutr. 2018;148(4):599–606. doi: https://doi.org/10.1093/jn/nxy001.
- US Food and Drug Administration. Guidance for Industry: Estimating Dietary Intake of Substances in Food, 2006.
- Polysorbate 80, 21 C.F.R. Sect. 172.840 2020.
- Substances Generally Recognized As Safe, 21 C.F.R. Sect . 182 2020.
- Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr. 1997;65(4 Suppl):1220S–8S. discussion 1229S-1231S. doi:https://doi.org/10.1093/ajcn/65.4.1220S
- Poti JM, Mendez MA, Ng SW, Popkin BM. Is the degree of food processing and convenience linked with the nutritional quality of foods purchased by US households?Am J Clin Nutr. 2015;101(6):1251–62. doi: https://doi.org/10.3945/ajcn.114.100925.
- Monteiro CA, Cannon G, Moubarac J-C, Levy RB, Louzada MLC, Jaime PC. The UN decade of nutrition, the NOVA food classification and the trouble with ultra-processing. Public Health Nutr. 2018;21(1):5–17. doi: https://doi.org/10.1017/S1368980017000234.
- Shams-White MM, Brockton NT, Mitrou P, Romaguera D, Brown S, Bender A, Kahle LL, Reedy J. Operationalizing the 2018 World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) cancer prevention recommendations: a standardized scoring system. Nutrients. 2019;11(7):1572. doi:https://doi.org/10.3390/nu1107
- Shams-White MM, Romaguera D, Mitrou P, Reedy J, Bender A, Brockton NT. Further guidance in implementing the standardized 2018 World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) score. Cancer Epidemiol Biomarkers Prev. 2020;29(5):889–94. doi: https://doi.org/10.1158/1055-9965.EPI-19-1444.
- Rock CL, Thomson C, Gansler T, Gapstur SM, McCullough ML, et al. American Cancer Society guideline for diet and physical activity for cancer prevention. CA Cancer J Clin. 2020. doi:https://doi.org/10.3322/caac.21591
- Stadlbauer V, Davies NA, Wright G, Jalan R. Endotoxin measures in patients’ sample: how valid are the results?J Hepatol. 2007;47(5):726–7. author reply 727-3. doi: https://doi.org/10.1016/j.jhep.2007.08.001.
- Newhall KJ, Diemer GS, Leshinsky N, Kerkof K, Chute HT, Russell CB, Rees W, Welcher AA, Patterson SD, Means GD, et al. Evidence for endotoxin contamination in plastic Na+-heparin blood collection tube lots. Clin Chem. 2010;56(9):1483–91. doi: https://doi.org/10.1373/clinchem.2006.144618.
- Gewirtz AT. Flag in the crossroads: flagellin modulates innate and adaptive immunity. Curr Opin Gastroenterol. 2006;22(1):8–12. doi:https://doi.org/10.1097/01.mog.0000194791.59337.28
- Sitaraman SV, Klapproth J-M, Moore DA, Landers C, Targan S, Williams IR, Gewirtz AT. Elevated flagellin-specific immunoglobulins in Crohn’s disease. Am J Physiol Gastrointest Liver Physiol. 2005;288(2):G403–6. doi: https://doi.org/10.1152/ajpgi.00357.2004.
- Kong SY, Tran HQ, Gewirtz AT, McKeown-Eyssen G, Fedirko V, Romieu I, Tjønneland A, Olsen A, Overvad K, Boutron-Ruault M-C, et al. Serum endotoxins and flagellin and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Cancer Epidemiol Biomarkers Prev. 2016;25(2):291–301. doi:https://doi.org/10.1158/1055-9965.EPI-15-0798
- Yang B, Bostick RM, Tran HQ, Gewirtz AT, Campbell PT, Fedirko V. Circulating biomarkers of gut barrier function: correlates and nonresponse to calcium supplementation among colon adenoma patients. Cancer Epidemiol Biomarkers Prev. 2016;25(2):318–26. doi:https://doi.org/10.1158/1055-9965.EPI-15-0488
- Etheredge AJ, Manji K, Kellogg M, Tran H, Liu E, McDonald CM, Kisenge R, Aboud S, Fawzi W, Bellinger D, et al. Markers of environmental enteric dysfunction are associated with neurodevelopmental outcomes in Tanzanian children. J Pediatr Gastroenterol Nutr. 2018;66(6):953–9. doi: https://doi.org/10.1097/MPG.0000000000001978.
- Würtz P, Kangas AJ, Soininen P, Lawlor DA, Davey Smith G, Ala-Korpela M. Quantitative serum nuclear magnetic resonance metabolomics in large-scale epidemiology: a primer on -omic technologies. Am J Epidemiol. 2017;186(9):1084–96. doi: https://doi.org/10.1093/aje/kwx016.
- Ritchie SC, Würtz P, Nath AP, Abraham G, Havulinna AS, Fearnley LG, Sarin A-P, Kangas AJ, Soininen P, Aalto K, et al. The biomarker GlycA is associated with chronic inflammation and predicts long-term risk of severe infection. Cell Syst. 2015;1(4):293–301. doi: https://doi.org/10.1016/j.cels.2015.09.007.
- Slifer ZM, Blikslager AT. The integral role of tight junction proteins in the repair of injured intestinal epithelium. IJMS. 2020;21(3):972. doi:https://doi.org/10.3390/ijms21030972
- Lerner A, Matthias T. Changes in intestinal tight junction permeability associated with industrial food additives explain the rising incidence of autoimmune disease. Autoimmun Rev. 2015;14(6):479–89. doi: https://doi.org/10.1016/j.autrev.2015.01.009.
- Groschwitz KR, Hogan SP. Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol. 2009;124(1):3–20. quiz 21-2. doi: https://doi.org/10.1016/j.jaci.2009.05.038.
- Tsilidis KK, Branchini C, Guallar E, Helzlsouer KJ, Erlinger TP, Platz EA. C-reactive protein and colorectal cancer risk: a systematic review of prospective studies. Int J Cancer. 2008;123(5):1133–40. doi: https://doi.org/10.1002/ijc.23606.
- Brennan CA, Garrett WS. Gut microbiota, inflammation, and colorectal cancer. Annu Rev Microbiol. 2016;70:395–411. doi: https://doi.org/10.1146/annurev-micro-102215-095513.
- Chassaing B, Van de Wiele T, De Bodt J, Marzorati M, Gewirtz AT. Dietary emulsifiers directly alter human microbiota composition and gene expression ex vivo potentiating intestinal inflammation. Gut. 2017;66(8):1414–27. doi: https://doi.org/10.1136/gutjnl-2016-313099.
- Weaver CM, Dwyer J, Fulgoni VL, King JC, Leveille GA, MacDonald RS, Ordovas J, Schnakenberg D. Processed foods: contributions to nutrition. Am J Clin Nutr. 2014;99(6):1525–42. doi: https://doi.org/10.3945/ajcn.114.089284.
- Landy J, Ronde E, English N, Clark SK, Hart AL, Knight SC, Ciclitira PJ, Al-Hassi HO. Tight junctions in inflammatory bowel diseases and inflammatory bowel disease associated colorectal cancer. World J Gastroenterol. 2016;22(11):3117–26. doi: https://doi.org/10.3748/wjg.v22.i11.3117.
- Rogler G, Rosano G. The heart and the gut. Eur Heart J. 2014;35(7):426–30. doi: https://doi.org/10.1093/eurheartj/eht271.
- Thaiss CA, Levy M, Grosheva I, Zheng D, Soffer E, Blacher E, Braverman S, Tengeler AC, Barak O, Elazar M, et al. Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection. Science. 2018;359(6382):1376–83. doi: https://doi.org/10.1126/science.aar3318.
- Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology. 2007;132(6):2169–80. doi:https://doi.org/10.1053/j.gastro.2007.03.059
- Lopes A, Araujo LF, Levy RB, Barreto SM, Giatti L. Association between consumption of ultra-processed foods and serum C-reactive protein levels: cross-sectional results from the ELSA-Brasil study. Sao Paulo Med J. 2019;137(2):169–76. doi: https://doi.org/10.1590/1516-3180.2018.0363070219.
- Duprez DA, Otvos J, Sanchez OA, Mackey RH, Tracy R, Jacobs DR. Comparison of the predictive value of GlycA and other biomarkers of inflammation for total death, incident cardiovascular events, noncardiovascular and noncancer inflammatory-related events, and total cancer events. Clin Chem. 2016;62(7):1020–31. doi: https://doi.org/10.1373/clinchem.2016.255828.
- Connelly MA, Otvos JD, Shalaurova I, Playford MP, Mehta NN. GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk. J Transl Med. 2017;15(1):219. doi: https://doi.org/10.1186/s12967-017-1321-6.